Schedule 13G ownership disclosure

Taysha Gene Therapies Inc

Security class unavailable · CUSIP: 877619106

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,179,000
Percent of class
5.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019231-21-000003
Form type
SC 13G
Filer
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
CIK
CIK 1019231
Filed
Feb 04, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub